We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ALINT market cap is 3.5M. The company's latest EPS is EUR -0.0259 and P/E is -20.46.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 8.32M | 9.15M | 11.46M | 13.38M | 12.83M |
Operating Income | -326k | -256k | -44k | -85k | -119k |
Net Income | -285k | -375k | 15k | -4k | -171k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 6.75M | 8.82M | 9.6M | 9.02M | 8M |
Total Liabilities | 4.24M | 6.65M | 7.42M | 6.84M | 5.99M |
Total Equity | 2.51M | 2.17M | 2.19M | 2.18M | 2.01M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | N/A | N/A | N/A | N/A | N/A |
Investing | N/A | N/A | N/A | N/A | N/A |
Financing | N/A | N/A | N/A | N/A | N/A |
Market Cap | 3.5M |
Price to Earnings Ratio | -20.46 |
Price to Sales Ratio | 0.27 |
Price to Cash Ratio | 1.91 |
Price to Book Ratio | 1.74 |
Dividend Yield | - |
Shares Outstanding | 6.6M |
Average Volume (1 week) | 7.1k |
Average Volume (1 Month) | 7.44k |
52 Week Change | -39.77% |
52 Week High | 0.93 |
52 Week Low | 0.434 |
Spread (Intraday) | 0.04 (7.66%) |
Company Name | Integragen |
Address |
genopole campus 1 - batiment 8 evry, essonne 91000 |
Website | https://www.integragen.fr |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions